Table 1.

Cumulative incidences of SC and SR to human CC reported in literature

	SC			SR
Country	n	Time	SC, %	n	Time	SR, %	Reference
Antibody based
Colombia	NA	NA	NA	23–32	1 year	43–34	Garcia et al.16
Peru	145	1 year	25	19	1 year	32	Garcia et al.16
	258	3 year	8	140	3 year	49	Garcia et al.16
Ecuador	288	6 month	9	135	6 month	19	Coral-Almeida et al.18
	226	7 month	7.5	101	7 month	26	Coral-Almeida et al.18
	264	13 month	9	120	13 month	28	Coral-Almeida et al.18
Zambia	106	6 month	17	55	6 month	35	Mwape et al.17
	107	6 month	21	54	6 month	26	Mwape et al.17
	106	1 year	24	55	1 year	33	Mwape et al.17
Antigen based
Ecuador	421	6 month	0.0	3	6 month	0.0	Coral-Almeida et al.18
	317	7 month	0.3	1	7 month	0.0	Coral-Almeida et al.18
	373	13 month	0.5	1	13 month	100	Coral-Almeida et al.18
Zambia	758	6 month	7	109	6 month	33	Mwape et al.17
	742	6 month	4	125	6 month	38	Mwape et al.17
	758	1 year	6	109	1 year	44	Mwape et al.17

SC = seroconversion; SR = seroreversion; NA = not available.